TYRA- Tyra Biosciences, Inc.

Name: Tyra Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Tyra Biosciences, Inc. (TYRA) has 12 insiders with recent SEC Form 4 filings, including 6 buys and 14 sells. TYRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Ra Capital Management, L.P.	10.26M	$351.84M	-
Dir	More Robert J	3.82M	$131.12M	-
CEO	Harris Todd	570.0K	$19.55M	-
COO	Ashar Bhavesh	300.0K	$10.29M	-
Other	Warner Douglas J	200.0K	$6.86M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 19, 2025	More Robert J64	Director	Sell	10,000	$25.00	$250,000.00	-0.3%	+49.7%	-
Dec 12, 2025	Bensen Daniel62	Chief Discovery Officer	Sell	8,000	$22.64	$181,159.20	-4.7%	+59.1%	-
Nov 21, 2025	More Robert J64	Director	Sell	246,871	$20.25	$5,000,026.49	-6.1%	+48.3%	-
Nov 19, 2025	Bensen Daniel62	Chief Operating Officer	Sell	125,589	$16.17	$2,030,923.43	-24.3%	+75.2%	-
Nov 17, 2025	Bensen Daniel62	Chief Operating Officer	Sell	131,411	$16.04	$2,108,066.96	-8.9%	+83.1%	-
Jun 18, 2025	Kaplan Gilla	Director	Sell	9,578	$9.78	$93,699.59	-12.7%	+30.1%	-
Jun 16, 2025	Kaplan Gilla	Director	Sell	51,814	$10.32	$534,563.41	-26.7%	+20.5%	-
Jun 16, 2025	Ra Capital Management, L.P.52	Director, 10% Owner	Buy	163,287	$10.19	$1,664,700.49	+0.5%	+20.5%	-
Jun 9, 2025	Ra Capital Management, L.P.52	Director, 10% Owner	Buy	186,850	$10.19	$1,904,001.50	+1.9%	+18.2%	-
Jun 5, 2025	Ra Capital Management, L.P.52	Director, 10% Owner	Buy	1,211,198	$9.70	$11,751,303.68	+6.6%	+21.1%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC